Journals / Toraks Dergisi / 2004 / Cilt: 5 - Sayı: 3

Clinical, radiologic and pleural fluid features of our patients with a diagnosis of pseudochylothorax

Psödoşilotoraks tanısı konulan hastalarımızın klinik, radyolojik ve plevral mayi özellikleri

Pages
171–176
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion when thoracentesis yields a milky or turbid fluid, differential diagnosis should include pseudochylothorax as well and pleural fluid cholesterol levels must be measured.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to evaluate the clinical, radiologic and pleural effusion findings of patients who were diagnosed as pseudochylothorax in our clinic between 1 July 1998 and 31 December 2003.
📊
Key Findings & Data:The study group included 5 male and 1 female patients aged 62 to 82 years with a mean age of 72 years.
💡
Conclusion & Impact:In conclusion when thoracentesis yields a milky or turbid fluid, differential diagnosis should include pseudochylothorax as well and pleural fluid cholesterol levels must be measured.
🔬Design:Review & Systematic Survey
📍Scope:2003 Verileri
⚙️Variables:Plörezi · Kolesterol · Trigliseridler

Abstract

The aim of this study was to evaluate the clinical, radiologic and pleural effusion findings of patients who were diagnosed as pseudochylothorax in our clinic between 1 July 1998 and 31 December 2003. The files and records of the patients who were diagnosed as pseudochylothorax in our clinic were retrospectively reviewed to identify patients and all the data including demographic characteristics, history, physical examination findings, pleural fluid features, radiographic features and spirometric studies. The study group included 5 male and 1 female patients aged 62 to 82 years with a mean age of 72 years. Two patients were symptomatic. Their past history were significant for tuberculosis. All the patients had been given antituberculous drugs. In additon to the medical therapy one patient with pulmonary tuberculosis had undergone collaps therapy and the other had undergone pulmonary resection. All of the pleural fluid were turbid and the turbidity persisted after centrifugation. Mean pleural fluid cholesterol level was 317.8 mg/dL (244-421 mg/dL) and cholesterol crystals were seen on microscopical examination of all pleural fluids. Spiral computed tomography revealed thickening and calcification of both parietal and visceral membranes and also some calcified foci in pleural fluids of four patients. There was no growth on tuberculosis culture of the pleural fluids. One patient who was diagnosed as peritoneal tuberculosis was given antituberculosis therapy, the patient with effort dyspnea undergone therapeutic thoracentesis. The other four patients were followed without treatment. In conclusion when thoracentesis yields a milky or turbid fluid, differential diagnosis should include pseudochylothorax as well and pleural fluid cholesterol levels must be measured. Especially, a past history of tuberculosis (pleural or pulmonary) and thickening and calcification of both parietal and visceral pleural membranes on thoracic CT scans strenghthen the diagnosis of pseudochylothorax.

Özet

Bu çalışma, 1 Temmuz 1998-31 Aralık 2003 döneminde psödoşilotoraks tanısı konulan hastalarımızın klinik, radyolojik ve plevral mayi özelliklerini değerlendirmek amacıyla yapıldı. Kliniğimizde psödoşilotoraks tanısı konulan hastaların dosya ve kayıtları, demografik özellikleri, öyküleri, fizik muayene bulguları, plevral mayi bulguları, radyolojik bulguları ve spirometrik çalışmaları yönünden geriye dönük olarak gözden geçirildi. Çalışma grubu, yaş ortalaması 72 olan (62-82) 5 erkek ve 1 kadın hastadan oluşuyordu. İki hasta semptomatikti. Hastaları n hepsinin öyküsünde tüberküloz bulunmaktaydı. Tüm hastalar tüberküloza yönelik medikal tedavi almıştı, ek olarak akciğer tüberkülozu geçiren iki hastadan birine kollaps tedavisi, diğerine de akciğer rezeksiyonu yapılmıştı. Tüm plevral mayiler bulanık görünümde olup bu bulanıklık santrifüj sonrası da devam etmekteydi. Plevral mayilerin kolesterol düzeyi ortalama 317.8 mg/dL (244-421 mg/dL) olup hepsinde de kolesterol kristalleri görüldü. Hastaların tümünün spiral bilgisayarlı tomografilerinde (BT) pariyetal ve viseral plevralar kalın ve kalsifiye idi. Dört hastanın plevral mayisinde kalsifiye odaklar izlendi. Plevral mayilerin hiçbirinin tüberküloz kültürlerinde üreme olmadı. Tüberküloz peritonit tanısı konulan bir hastaya antitüberküloz tedavi başlanırken, efor dispnesi olan hastaya terapötik torasentez yapıldı. Diğer dört hasta tedavisiz olarak izleme alındı. Sonuç olarak, bulanık görünümlü plevral mayilerin ayırıcı tanısında psödoşilotoraks da düşünülmeli ve plevral mayinin kolesterol düzeyleri ölçülmelidir. Özellikle uzun süre önce tüberküloz (plevral veya akciğer) öyküsü varlığı ve toraks BT’de pariyetal ve viseral plevraların kalın ve kalsifiye görülmesi psödoşilotoraks olasılığını güçlendirmektedir.

🔖

Cite This Article

FINDIK, S., ATICI, A. G., UZUN, O., ERKAN, L. (2004). Clinical, radiologic and pleural fluid features of our patients with a diagnosis of pseudochylothorax. Toraks Dergisi, Cilt: 5 - Sayı: 3, 171–176. https://ajindex.com/articles/368125

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Prakash UBS. Chylothorax and pseudochylothorax. European Respiratory Monograph 2002;22:249-65
  2. Özlü T. Plevral sıvılarda tanı. Toraks Dergisi 2000;2:85-92
  3. Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo FJ et al. Pseudochylothorax. Report of 2 cases and review of the literature. Medicine 1999; 78:200-7
  4. Erkan ML, Atıcı AG, Fındık S. A case of pseudochylothorax. Turkish Respiratory Journal 2001;2:23-5
  5. Coe JE, Aikawa JK. Cholesterol pleural effusion. Arch Intern Med 1961;108:763-74
  6. Ferguson GC. Cholesterol pleural effusion in rheumatoid lung disease. Thorax 1966;21:577-82
  7. Goldman A, Burdorf TH. Cholesterol pleural effusion: a report of three cases with a cure by decortication. Dis Chest 1950;18:586-94
  8. Light RW. Pleural diseases, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001
  9. Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997; 10:1157-62
  10. Hamm H, Pfalzer B, Fabel H. Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis. Respiration 1991;58:294-300
  11. Staats BA, Ellefson RW, Budahn LL et al. The lipoprotein profile of chylous and non-chylous pleural effusions. Mayo Clin Proc 1980;55: 700-4
  12. Debieuvre D, Gury JP, Ory P, Jobard JM. Association psudochylothorax et tuberculose pleurale. Rev Pneumol Clin 1994;50:175-7.